Erratum for John Mattila, Mike Clark, Shengjiang Liu, et al.:“Retrospective Evaluation of Low-pH Viral Inactivation and Viral Filtration Data from a Multiple Company …

J Mattila, M Clark, S Liu, J Pieracci… - PDA Journal of …, 2018 - journal.pda.org
Erratum for John Mattila, Mike Clark, Shengjiang Liu, et al.: “Retrospective Evaluation of Low-pH
Viral Inactivation and Viral Filtration Data from a Multiple Company Collaboration” | PDA …

Erratum: Retrospective Evaluation of Low-pH Viral Inactivation and Viral Filtration Data from a Multiple Company Collaboration

J Mattila, M Clark, S Liu, J Pieracci… - PDA Journal of …, 2018 - journal.pda.org
Ref: Retrospective Evaluation of Low-pH Viral Inactivation and Viral Filtration Data from a
Multiple Company Collaboration John Mattila, Mike Clark, Shengjiang Liu, et al. PDA J …

Erratum: Nature‑The great leveller: It is a way to end the COVID era?

R Sardana, L Mendiratta, H Butta - journals.lww.com
In the article titled “Nature‑The great leveller: It is a way to end the COVID era?”, published
on pages 60‑61, Issue 2, Volume 9 of Journal of Patient Safety & Infection Control,[1] the title …

[CITATION][C] Erratum: Antivirals become a broader enterprise

JL Fox - Nature Biotechnology, 2008 - nature.com
In the version of this article initially published, in paragraph 7, beginning with line 2, the
author incorrectly stated that “genes and promoters” were to be used; the line should have …

[CITATION][C] Erratum to: Pilot and Feasibility Studies, Vol. 4

… Feasibility Studies info@ biomedcentral. com. uk - Pilot and Feasibility …, 2017 - Springer
An error occurred during the publication of a number of articles in Pilot and Feasibility
Studies. These articles were erroneously published in volume number 4, which is listed with …

[PDF][PDF] Evidence for contribution of boosting Ritonavir (Kaletra®) to viral protease inhibition in vivo

M Ehrhardt, M Moeck, WE Haefeli… - EUROPEAN …, 2005 - researchgate.net
Evidence for contribution of boosting Ritonavir (Kaletra®) to viral protease inhibition in vivo Page
1 A B C A B C 0 5 10 15 20 study part A U C [h *m g/L ] plasma cells A B C A B C 0 0,5 1 1,5 2 2,5 …

Proceedings of the 2017 Viral Clearance Symposium, Session 3: Resin Lifetime

J Blümel, J Ma - PDA Journal of Pharmaceutical Science and …, 2018 - journal.pda.org
In many downstream processes, chromatographic purification steps contribute significantly
to the overall virus reduction capacity. The International Conference on Harmonisation of …

Erratum:(Clinical Microbiology and Infection (2008) vol. 14)

G Cornaglia, J Garau… - Clinical Microbiology …, 2008 - researchportal.ukhsa.gov.uk
Erratum: (Clinical Microbiology and Infection (2008) vol. 14) — UK Health Security Agency Skip
to main navigation Skip to search Skip to main content UK Health Security Agency Main UK …

[CITATION][C] Erratum: Who's who in biotech

C Sheridan - Nature Biotechnology, 2006 - nature.com
Erratum: Who’s who in biotech Erratum: Who’s who in biotech Erratum: Who’s who in biotech
Erratum: Gene prioritization thr Page 1 NATURE BIOTECHNOLOGY VOLUME 24 NUMBER 6 …

ERRATUM Open Access

I Vilcu, I Mathauer - 2016 - equityhealthj.biomedcentral.com
Unfortunately, after publication of this article [1] it was noticed that the copyright statement is
incorrect. The corrected copyright statement can be seen below:© 2016 World Health …